Tham khảo Prasterone

  1. 1 2 3 4 5 J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 641–. ISBN 978-1-4757-2085-3.
  2. ↑ James Devillers (27 tháng 4 năm 2009). Endocrine Disruption Modeling. CRC Press. tr. 339–. ISBN 978-1-4200-7636-3.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Melanie Johns Cupp; Timothy S. Tracy (10 tháng 12 năm 2002). Dietary Supplements: Toxicology and Clinical Pharmacology. Springer Science & Business Media. tr. 123–147. ISBN 978-1-59259-303-3.
  4. 1 2 B.J. Oddens; A. Vermeulen (15 tháng 11 năm 1996). Androgens and the Aging Male. CRC Press. tr. 5–. ISBN 978-1-85070-763-9.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Rutkowski K, Sowa P, Rutkowska-Talipska J, Kuryliszyn-Moskal A, Rutkowski R (tháng 7 năm 2014). “Dehydroepiandrosterone (DHEA): hypes and hopes”. Drugs. 74 (11): 1195–207. doi:10.1007/s40265-014-0259-8. PMID 25022952.
  6. 1 2 3 4 5 6 7 8 9 Prough RA, Clark BJ, Klinge CM (tháng 4 năm 2016). “Novel mechanisms for DHEA action”. J. Mol. Endocrinol. 56 (3): R139–55. doi:10.1530/JME-16-0013. PMID 26908835.
  7. ↑ Arlt, W (tháng 9 năm 2004). “Dehydroepiandrosterone and ageing”. Best Practice & Research. Clinical Endocrinology & Metabolism. 18 (3): 363–80. doi:10.1016/j.beem.2004.02.006. PMID 15261843.
  8. ↑ Alkatib, AA; Cosma, M; Elamin, MB; Erickson, D; Swiglo, BA; Erwin, PJ; Montori, VM (tháng 10 năm 2009). “A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency”. The Journal of Clinical Endocrinology and Metabolism. 94 (10): 3676–81. doi:10.1210/jc.2009-0672. PMID 19773400.
  9. ↑ Rogerio A. Lobo (5 tháng 6 năm 2007). Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Academic Press. tr. 821–828. ISBN 978-0-08-055309-2.
  10. ↑ https://www.drugs.com/international/gynodian-depot.html
  11. ↑ J. Horsky; J. Presl (6 tháng 12 năm 2012). Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. tr. 146–. ISBN 978-94-009-8195-9.
  12. ↑ D. Platt (6 tháng 12 năm 2012). Geriatrics 3: Gynecology · Orthopaedics · Anesthesiology · Surgery · Otorhinolaryngology · Ophthalmology · Dermatology. Springer Science & Business Media. tr. 6–. ISBN 978-3-642-68976-5.
  13. ↑ S. Campbell (6 tháng 12 năm 2012). The Management of the Menopause & Post-Menopausal Years: The Proceedings of the International Symposium held in London 24–26 November 1975 Arranged by the Institute of Obstetrics and Gynaecology, The University of London. Springer Science & Business Media. tr. 395–. ISBN 978-94-011-6165-7.
  14. ↑ Carrie Bagatell; William J. Bremner (27 tháng 5 năm 2003). Androgens in Health and Disease. Springer Science & Business Media. tr. 277–. ISBN 978-1-59259-388-0.
  15. ↑ Frigo P, Eppel W, Asseryanis E, Sator M, Golaszewski T, Gruber D, Lang C, Huber J (1995). “The effects of hormone substitution in depot form on the uterus in a group of 50 perimenopausal women--a vaginosonographic study”. Maturitas. 21 (3): 221–5. doi:10.1016/0378-5122(94)00893-c. PMID 7616871.
  16. ↑ http://adisinsight.springer.com/drugs/800032054
  17. 1 2 https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208470s000lbl.pdf
  18. ↑ https://www.drugs.com/international/mylis.html
  19. ↑ “Prasterone vaginal - Kanebo - AdisInsight”.
  20. ↑ John W. Blunt; Murray H. G. Munro (19 tháng 9 năm 2007). Dictionary of Marine Natural Products with CD-ROM. CRC Press. tr. 1075–. ISBN 978-0-8493-8217-8.
  21. ↑ A. Kleemann; J. Engel; B. Kutscher; D. Reichert (14 tháng 5 năm 2014). Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs. Thieme. tr. 2441–2442. ISBN 978-3-13-179525-0.
  22. ↑ Martin Negwer; Hans-Georg Scharnow (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. tr. 1831. ISBN 978-3-527-30247-5. 3β-Hydroxyandrost-5-en-17-one hydrogen sulfate = (3β)-3-(Sulfooxy)androst-5-en-17-one. R: Sodium salt (1099-87-2). S: Astenile, Dehydroepiandrosterone sulfate sodium, DHA-S, DHEAS, KYH 3102, Mylis, PB 005, Prasterone sodium sulfate, Teloin
  23. ↑ Jianqiu, Y (1992). “Clinical Application of Prasterone Sodium Sulfate”. Chinese Journal of New Drugs. 5: 015.
  24. ↑ Sakaguchi M, Sakai T, Adachi Y, Kawashima T, Awata N (1992). “The biological fate of sodium prasterone sulfate after vaginal administration. I. Absorption and excretion in rats”. J. Pharmacobio-dyn. 15 (2): 67–73. doi:10.1248/bpb1978.15.67. PMID 1403604.
  25. ↑ Sakai, T.; Sakaguchi, M.; Adachi, Y.; Kawashima, T.; Awata, N. (1992). “The Biological Fate of Sodium Prasterone Sulfate after Vaginal Administration II: Distribution after Single and Multiple Administration to Pregnant Rats”. 薬物動態. 7 (1): 87–101. doi:10.2133/dmpk.7.87.
  26. 1 2 3 4 5 6 7 Ades TB biên tập (2009). DHEA. American Cancer Society Complete Guide to Complementary and Alternative Cancer Therapies (ấn bản 2). American Cancer Society. tr. 729–33. ISBN 9780944235713.
  27. 1 2 3 4 Medscape (2010). “DHEA Oral”. Drug Reference. WebMD LLC. Truy cập ngày 18 tháng 2 năm 2010.
  28. ↑ Chang DM, Lan JL, Lin HY, Luo SF (2002). “Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial”. Arthritis Rheum. 46 (11): 2924–27. doi:10.1002/art.10615. PMID 12428233.
  29. ↑ Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ, Ferrando SJ (2006). “Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS”. Am J Psychiatry. 163 (1): 59–66. doi:10.1176/appi.ajp.163.1.59. PMID 16390890.
  30. ↑ Brooke AM, Kalingag LA, Miraki-Moud F, Camacho-Hübner C, Maher KT, Walker DM, Hinson JP, Monson JP (2006). “Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement”. J Clin Endocrinol Metab. 91 (10): 3773–79. doi:10.1210/jc.2006-0316. PMID 16849414.
  31. ↑ Villareal DT, Holloszy JO (2006). “DHEA enhances effects of weight training on muscle mass and strength in elderly women and men”. Am J Physiol Endocrinol Metab. 291 (5): E1003–08. doi:10.1152/ajpendo.00100.2006. PMID 16787962.
  32. ↑ Medline Plus. “DHEA”. Drugs and Supplements Information. National Library of Medicine. Truy cập ngày 18 tháng 2 năm 2010.
  33. 1 2 3 4 5 Douglas McKeag; James L. Moeller (2007). ACSM's Primary Care Sports Medicine. Lippincott Williams & Wilkins. tr. 616–. ISBN 978-0-7817-7028-6.
  34. ↑ “DHEA: Side effects and safety”. WebMD. Truy cập ngày 24 tháng 7 năm 2012.
  35. 1 2 Casson PR, Straughn AB, Umstot ES, Abraham GE, Carson SA, Buster JE (tháng 2 năm 1996). “Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration”. Am. J. Obstet. Gynecol. 174 (2): 649–53. doi:10.1016/S0002-9378(96)70444-1. PMID 8623801.
  36. ↑ Kuhl, Herbert; Taubert, Hans-Dieter (1987). Das Klimakterium – Pathophysiologie, Klinik, Therapie [The Climacteric – Pathophysiology, Clinic, Therapy] (bằng tiếng Đức). Stuttgart, Germany: Thieme Verlag. tr. 122. ISBN 978-3137008019.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  37. ↑ Düsterberg B, Wendt H (1983). “Plasma levels of dehydroepiandrosterone and 17 beta-estradiol after intramuscular administration of Gynodian-Depot in 3 women”. Horm. Res. 17 (2): 84–9. doi:10.1159/000179680. PMID 6220949.
  38. ↑ Rauramo L, Punnonen R, Kaihola LH, Grönroos M (tháng 1 năm 1980). “Serum oestrone, oestradiol and oestriol concentrations in castrated women during intramuscular oestradiol valerate and oestradiolbenzoate-oestradiolphenylpropionate therapy”. Maturitas. 2 (1): 53–8. doi:10.1016/0378-5122(80)90060-2. PMID 7402086.
  39. 1 2 3 4 5 Carl A. Burtis; Edward R. Ashwood; David E. Bruns (14 tháng 10 năm 2012). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics - E-Book. Elsevier Health Sciences. tr. 1856–. ISBN 978-1-4557-5942-2.
  40. ↑ Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA (2015). “The Regulation of Steroid Action by Sulfation and Desulfation”. Endocr. Rev. 36 (5): 526–63. doi:10.1210/er.2015-1036. PMC 4591525. PMID 26213785.
  41. ↑ Labrie F, Martel C, Bélanger A, Pelletier G (tháng 4 năm 2017). “Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology”. J. Steroid Biochem. Mol. Biol. 168: 9–18. doi:10.1016/j.jsbmb.2016.12.007. PMID 28153489.
  42. 1 2 3 Paul M. Coates; M. Coates Paul; Marc Blackman; Marc R. Blackman, Gordon M. Cragg, Mark Levine, Jeffrey D. White, Joel Moss, Mark A. Levine (29 tháng 12 năm 2004). Encyclopedia of Dietary Supplements (Print). CRC Press. tr. 169–. ISBN 978-0-8247-5504-1.Quản lý CS1: nhiều tên: danh sách tác giả (liên kết)
  43. 1 2 Schwartz AG, Pashko LL (2004). “Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity”. Ageing Res. Rev. 3 (2): 171–87. doi:10.1016/j.arr.2003.05.001. PMID 15177053.
  44. ↑ Mortola JF, Yen SS (1990). “The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women”. J. Clin. Endocrinol. Metab. 71 (3): 696–704. doi:10.1210/jcem-71-3-696. PMID 2144295.
  45. ↑ Edith Josephy; F. Radt (1 tháng 12 năm 2013). Elsevier's Encyclopaedia of Organic Chemistry: Series III: Carboisocyclic Condensed Compounds. Springer. tr. 2608–. ISBN 978-3-662-25863-7.
  46. ↑ NSCA-National Strength & Conditioning Association (27 tháng 1 năm 2017). NSCA'S Essentials of Tactical Strength and Conditioning. Human Kinetics. tr. 130–. ISBN 978-1-4504-5730-9.
  47. ↑ Detlef Thieme; Peter Hemmersbach (18 tháng 12 năm 2009). Doping in Sports. Springer Science & Business Media. tr. 137–. ISBN 978-3-540-79088-4.
  48. ↑ Parr MK, Opfermann G, Geyer H, Westphal F, Sönnichsen FD, Zapp J, Kwiatkowska D, Schänzer W (2011). “Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination”. Steroids. 76 (6): 540–7. doi:10.1016/j.steroids.2011.02.001. PMID 21310167.
  49. ↑ https://mednet-communities.net/inn/db/media/docs/p-innlist23.pdf
  50. ↑ https://mednet-communities.net/inn/db/media/docs/r-innlist18.pdf
  51. ↑ Hoyme U, Baumueller A, Madsen PO (1978). “The influence of pH on antimicrobial substances in canine vaginal and urethral secretions”. Urol. Res. 6 (1): 35–42. PMID 25506.
  52. ↑ Kopera, H.; Dhont, M.; Dienstl, F.; Gambrell, R. D.; Gordan, G. S.; Heidenreich, J.; Lachnit-Fixon, U.; Lauritzen, C.; Lebech, P. E. (1979). “Effects, side-effects, and dosage schemes of various sex hormones in the peri- and post-menopause”. Female and Male Climacteric. tr. 43–67. doi:10.1007/978-94-011-9720-5_6. ISBN 978-94-011-9722-9.
  53. ↑ Mattson LA, Cullberg G, Tangkeo P, Zador G, Samsioe G (tháng 12 năm 1980). “Administration of dehydroepiandrosterone enanthate to oophorectomized women--effects on sex hormones and lipid metabolism”. Maturitas. 2 (4): 301–9. doi:10.1016/0378-5122(80)90032-8. PMID 6453267.
  54. ↑ Muller (19 tháng 6 năm 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. tr. 566–. ISBN 978-3-7692-2114-5.
  55. 1 2 C.W. Randolph, Jr., M.D.; Genie James (1 tháng 1 năm 2010). From Hormone Hell to Hormone Well: Straight Talk Women (and Men) Need to Know to Save Their Sanity, Health, and—Quite Possibly—Their Lives. Health Communications, Incorporated. tr. 72–. ISBN 978-0-7573-9759-2.Quản lý CS1: nhiều tên: danh sách tác giả (liên kết)
  56. ↑ Marie Dunford; J. Andrew Doyle (7 tháng 2 năm 2014). Nutrition for Sport and Exercise. Cengage Learning. tr. 442–. ISBN 978-1-285-75249-5.
  57. 1 2 “Prasterone - Genelabs - AdisInsight”.
  58. ↑ Sheldon Blau; Dodi Schultz (5 tháng 3 năm 2009). Living With Lupus: The Complete Guide, 2nd Edition. Da Capo Press. tr. 138–. ISBN 978-0-7867-2985-2.
  59. 1 2 Voelker, Rebecca (2017). “Relief for Painful Intercourse”. JAMA. 317 (1): 18. doi:10.1001/jama.2016.19077. ISSN 0098-7484. PMID 28030684.
  60. ↑ “Prasterone (Intrarosa) for Dyspareunia”. JAMA. 318 (16): 1607. 2017. doi:10.1001/jama.2017.14981. ISSN 0098-7484.
  61. ↑ I.K. Morton; Judith M. Hall (6 tháng 12 năm 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. tr. 92, 96, 230. ISBN 978-94-011-4439-1.
  62. 1 2 “Prasterone”.
  63. ↑ “Drug Information Portal - U.S. National Library of Medicine - Quick Access to Quality Drug Information”.
  64. ↑ Calfee, R.; Fadale, P. (tháng 3 năm 2006). “Popular ergogenic drugs and supplements in young athletes”. Pediatrics. 117 (3): e577–89. doi:10.1542/peds.2005-1429. PMID 16510635. In 2004, a new Steroid Control Act that placed androstenedione under Schedule III of controlled substances effective January 2005 was signed. DHEA was not included in this act and remains an over-the-counter nutritional supplement.
  65. ↑ “Drug Scheduling Actions – 2005”. Drug Enforcement Administration.
  66. ↑ Corona, G; Rastrelli, G; Giagulli, VA; Sila, A; Sforza, A; Forti, G; Mannucci, E; Maggi, M (2013). “Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials”. J. Clin. Endocrinol. Metab. 98 (9): 3615–26. doi:10.1210/jc.2013-1358. PMID 23824417.
  67. ↑ Baker, WL; Karan, S; Kenny, AM (tháng 6 năm 2011). “Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review”. Journal of the American Geriatrics Society. 59 (6): 997–1002. doi:10.1111/j.1532-5415.2011.03410.x. PMID 21649617.
  68. ↑ Wallace, M. B.; Lim, J.; Cutler, A.; Bucci, L. (1999). “Effects of dehydroepiandrosterone vs androstenedione supplementation in men”. Medicine and Science in Sports and Exercise. 31 (12): 1788–92. doi:10.1097/00005768-199912000-00014. PMID 10613429.